Your browser doesn't support javascript.
loading
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
Tiono, Alfred B; Nébié, Issa; Anagnostou, Nicholas; Coulibaly, Aboubacar S; Bowyer, Georgina; Lam, Erika; Bougouma, Edith C; Ouedraogo, Alphonse; Yaro, Jean Baptist B; Barry, Aïssata; Roberts, Rachel; Rampling, Tommy; Bliss, Carly; Hodgson, Susanne; Lawrie, Alison; Ouedraogo, Amidou; Imoukhuede, Egeruan Babatunde; Ewer, Katie J; Viebig, Nicola K; Diarra, Amidou; Leroy, Odile; Bejon, Philip; Hill, Adrian V S; Sirima, Sodiomon B.
Afiliação
  • Tiono AB; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Nébié I; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Anagnostou N; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Coulibaly AS; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Bowyer G; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Lam E; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Bougouma EC; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Ouedraogo A; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Yaro JBB; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Barry A; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Roberts R; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Rampling T; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Bliss C; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Hodgson S; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Lawrie A; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Ouedraogo A; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Imoukhuede EB; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Ewer KJ; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Viebig NK; European Vaccine Initiative, Universitäts Klinikum Heidelberg, Heidelberg, Germany.
  • Diarra A; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Leroy O; European Vaccine Initiative, Universitäts Klinikum Heidelberg, Heidelberg, Germany.
  • Bejon P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Hill AVS; The Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Sirima SB; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
PLoS One ; 13(12): e0208328, 2018.
Article em En | MEDLINE | ID: mdl-30540808
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Antimaláricas Tipo de estudo: Clinical_trials Limite: Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Antimaláricas Tipo de estudo: Clinical_trials Limite: Female / Humans / Infant / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article